Transmembrane
signaling
by
plant
receptor
kinases
(RKs)
has
long
been
thought
to
involve
reciprocal
trans-phosphorylation
of
their
intracellular
kinase
domains.
The
fact
that
many
these
are
pseudokinase
domains,
however,
suggests
additional
mechanisms
must
govern
RK
activation.
Non-catalytic
(pseudo)kinase
have
described
in
metazoans,
but
information
is
scarce
for
plants.
Recently,
a
non-catalytic
function
was
reported
the
leucine-rich
repeat
(LRR)-RK
subfamily
XIIa
member
EFR
(ELONGATION
FACTOR
TU
RECEPTOR)
and
phosphorylation-dependent
conformational
changes
were
proposed
regulate
RKs
with
non-RD
Here,
using
as
model,
we
describe
activation
mechanism
LRR-RKs
an
active
kinase,
kinase-dead
variant
retains
ability
enhance
catalytic
activity
its
co-receptor
BAK1/SERK3
(BRASSINOSTEROID
INSENSITIVE
1-ASSOCIATED
KINASE
1/SOMATIC
EMBRYOGENESIS
RECEPTOR
3).
Applying
hydrogen-deuterium
exchange
mass
spectrometry
(HDX-MS)
analysis
designing
homology-based
intragenic
suppressor
mutations,
provide
evidence
domain
adopt
conformation
order
activate
BAK1
allosterically,
likely
supporting
αC-helix
positioning
BAK1.
Our
results
suggest
toggle
model
signaling,
which
first
phosphorylates
loop
stabilize
conformation,
allowing
turn
allosterically
Oncogene,
Год журнала:
2024,
Номер
43(26), С. 1973 - 1984
Опубликована: Май 21, 2024
Abstract
The
generation
of
drugs
counteracting
deregulated
protein
kinases
has
been
a
major
focus
in
cancer
therapy
development.
Breakthroughs
this
effort
have
produced
many
therapeutic
agents
to
the
benefit
patients,
mostly
through
development
chemical
or
antibody-based
targeting
active
kinases.
These
strategies
are
challenged
when
considering
catalytically
inactive
(or
pseudokinases),
which
represent
10%
human
kinome
with
relevance
cancer.
Among
so-called
pseudotyrosine
kinases,
PTK7
receptor
tyrosine
kinase
(RTK)
stands
as
bona
fide
target
overexpressed
several
solid
tumors
and
hematological
malignancies
linked
metastasis,
poor
prognosis,
resistance
treatment.
Despite
lack
catalytic
activity,
signaling
capacities
heterodimerization
RTKs
offers
pharmacological
opportunities
its
domain.
Moreover,
PTK7-targeting
based
on
antibody-drug
conjugates,
aptamers,
CAR-T
cell-based
therapies
demonstrated
encouraging
results
preclinical
clinical
settings.
We
review
most
recent
data
assigning
prominent
role
progression
well
current
against
RTK
family
pseudokinases
including
PTK7.
Oncogene,
Год журнала:
2024,
Номер
43(29), С. 2253 - 2265
Опубликована: Май 28, 2024
Abstract
Genetic
changes
in
the
ERBB
family
of
receptor
tyrosine
kinases
serve
as
oncogenic
driver
events
and
predictive
biomarkers
for
inhibitor
drugs.
ERBB3
is
a
pseudokinase
member
that,
although
lacking
fully
active
kinase
domain,
well
known
its
potent
signaling
activity
heterodimeric
complex
with
ERBB2.
Previous
studies
have
identified
few
transforming
mutations
while
great
majority
hundreds
different
somatic
variants
observed
cancer
types
remain
unknown
significance.
Here,
we
describe
an
unbiased
functional
genetics
screen
potential
thousands
parallel.
The
based
on
previously
described
iSCREAM
(in
vitro
activating
mutations)
platform,
addressing
context
ERBB3/ERBB2
heterodimers,
18
hit
mutations.
Validation
experiments
Ba/F3,
NIH
3T3,
MCF10A
cell
backgrounds
demonstrated
presence
both
missense
functioning
either
single
or
cis
pairwise
combination.
Drug
sensitivity
assays
trastuzumab,
pertuzumab
neratinib
indicated
actionability
variants.
Transmembrane
signaling
by
plant
receptor
kinases
(RKs)
has
long
been
thought
to
involve
reciprocal
trans-phosphorylation
of
their
intracellular
kinase
domains.
The
fact
that
many
these
are
pseudokinase
domains,
however,
suggests
additional
mechanisms
must
govern
RK
activation.
Non-catalytic
protein
domains
have
described
in
metazoans,
but
information
is
scarce
for
plants.
Recently,
a
non-catalytic
function
was
reported
the
leucine-rich
repeat
(LRR)-RK
subfamily
XIIa
member
EFR
(elongation
factor
Tu
receptor)
and
phosphorylation-dependent
conformational
changes
were
proposed
regulate
RKs
with
non-RD
Here,
using
as
model,
we
describe
activation
mechanism
LRR-RKs
an
active
kinase,
kinase-dead
variant
retains
ability
enhance
catalytic
activity
its
co-receptor
BAK1/SERK3
(brassinosteroid
insensitive
1-associated
1/somatic
embryogenesis
3).
Applying
hydrogen-deuterium
exchange
mass
spectrometry
(HDX-MS)
analysis
designing
homology-based
intragenic
suppressor
mutations,
provide
evidence
domain
adopt
conformation
order
activate
BAK1
allosterically,
likely
supporting
αC-helix
positioning
BAK1.
Our
results
suggest
toggle
model
signaling,
which
first
phosphorylates
loop
stabilize
conformation,
allowing
turn
allosterically
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 15, 2025
Bacterial
serine-threonine
protein
kinases
(STKs)
regulate
diverse
cellular
processes
associated
with
cell
growth,
virulence,
and
pathogenicity.
They
are
evolutionarily
related
to
the
druggable
eukaryotic
STKs.
However,
an
incomplete
knowledge
of
how
bacterial
STKs
differ
from
their
counterparts
they
have
diverged
signaling
functions
presents
a
bottleneck
in
targeting
them
for
drug
discovery
efforts.
Here,
we
classified
over
300,000
STK
sequences
NCBI
RefSeq
non-redundant
UniProt
databases
into
35
canonical
seven
non-canonical
(pseudokinase)
families
based
on
patterns
evolutionary
constraints
conserved
catalytic
domain
flanking
regulatory
domains.
Through
statistical
comparisons,
identified
distinguishing
features
STKs,
including
distinctive
arginine
residue
helix
(C-Helix)
that
dynamically
couples
ATP
substrate
binding
lobes
kinase
domain.
Biochemical
peptide-library
screens
demonstrated
constrained
residues
contribute
specificity
activation
Mycobacterium
tuberculosis
PknB.
Collectively,
these
findings
open
new
avenues
investigating
development
selective
inhibitors.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Март 2, 2025
SUMMARY
Receptor-like
kinases
(RLKs),
particularly
the
Transmembrane
Kinase
(TMK)
family,
play
essential
roles
in
signaling
and
development,
with
TMKs
being
key
components
of
auxin
perception
downstream
phosphorylation
events.
While
TMKs’
involvement
canalization,
a
process
for
vasculature
formation
regeneration,
has
been
established,
nonetheless,
additional
regulatory
partners
remain
poorly
understood.
In
this
study,
we
identify
characterize
seven
leucine-rich
repeat
RLKs
(TINT1–TINT7)
as
novel
interactors
TMK1,
revealing
their
diverse
evolutionary,
structural,
functional
characteristics.
Our
results
show
that
TINTs
interact
TMK1
highlight
regulating
various
developmental
processes.
Majority
contributes,
together
to
TINT5
linking
other
canalization
component
CAMEL.
Beyond
also
establish
role
TINT-TMK1
interactions
processes
such
stomatal
movement
hypocotyl’s
gravitropic
response.
These
findings
suggest
TINTs,
through
interaction
are
integral
networks,
contributing
both
broader
plant
development.
Frontiers in Biophysics,
Год журнала:
2025,
Номер
3
Опубликована: Апрель 4, 2025
TBCK
is
an
essential
protein
in
neurodevelopment.
Mutations
the
gene
are
associated
with
Syndrome,
a
genetic
neurological
disorder
characterized
by
global
developmental
delay.
enigmatic
multidomain
that
contains
pseudokinase
domain,
TBC
(Tre2-Bub2-Cdc16)
and
rhodanese-like
domain.
Emerging
evidence
increasingly
links
to
multiple
cellular
processes,
including
mTOR
signaling,
autophagy,
lysosomal
function,
mitochondrial
maintenance.
This
review
consolidates
recent
advances
our
understanding
of
TBCK,
emphasizing
comparative
sequence
analysis,
structural
modeling,
its
functions.
Our
analysis
shows
both
kinase
domain
likely
lack
catalytic
activity
instead
primarily
function
as
scaffolds
or
regulatory
domains.
The
all
conserved
residues,
suggesting
it
may
act
GTPase-activating
(GAP).
These
functional
hypotheses
provide
foundation
for
further
investigations
into
TBCK’s
physiological
pathological
roles.
Science Signaling,
Год журнала:
2025,
Номер
18(885)
Опубликована: Май 6, 2025
Bacterial
serine-threonine
kinases
(STKs)
regulate
diverse
cellular
processes
associated
with
cell
growth,
virulence,
and
pathogenicity
are
evolutionarily
related
to
the
druggable
eukaryotic
STKs.
A
deeper
understanding
of
how
bacterial
STKs
differ
from
their
counterparts
they
have
evolved
signaling
functions
is
crucial
for
advancing
discovery
development
new
antibiotic
therapies.
Here,
we
classified
more
than
300,000
STK
sequences
NCBI
RefSeq
nonredundant
UniProt
protein
databases
into
35
canonical
seven
pseudokinase
families
on
basis
patterns
evolutionary
constraints
in
conserved
catalytic
domain
flanking
regulatory
domains.
Through
statistical
comparisons,
identified
features
distinguishing
STKs,
including
an
arginine
residue
a
helix
(C
helix)
that
dynamically
couples
ATP-
substrate-binding
lobes
kinase
domain.
Biochemical
peptide
library
screens
demonstrated
constrained
residues
contributed
substrate
specificity
activation
Mycobacterium
tuberculosis
PknB.
Together,
these
findings
open
previously
unidentified
avenues
investigating
developing
selective
inhibitors.
Journal of Medicinal Chemistry,
Год журнала:
2023,
Номер
66(16), С. 10959 - 10990
Опубликована: Авг. 14, 2023
The
Janus
kinases
(JAKs)
are
key
components
of
the
JAK-STAT
signaling
pathway
and
involved
in
myriad
physiological
processes.
Though
they
molecular
targets
many
FDA-approved
drugs,
these
drugs
manifest
adverse
effects
due
part
to
their
inhibition
requisite
JAK
kinase
activity.
However,
JAKs
uniquely
possess
an
integrated
pseudokinase
domain
(JH2)
that
regulates
adjacent
(JH1).
therapeutic
targeting
JH2
domains
has
been
less
thoroughly
explored
may
present
avenue
modulate
without
associated
with
JH1
domain.
potential
this
strategy
was
recently
demonstrated
FDA
approval
TYK2
ligand
deucravacitinib
for
treating
plaque
psoriasis.
In
light,
structure
targetability
pseudokinases
discussed,
conjunction
state
development
ligands
bind
domains.
Abstract
Temozolomide
(TMZ)
represents
the
cornerstone
of
therapy
for
glioblastoma
(GBM).
However,
acquisition
resistance
limits
its
therapeutic
potential.
The
human
kinome
is
an
undisputable
source
druggable
targets,
still,
current
knowledge
remains
confined
to
a
limited
fraction
it,
with
multitude
under‐investigated
proteins
yet
be
characterized.
Here,
following
kinome‐wide
RNAi
screen,
pantothenate
kinase
4
(PANK4)
isuncovered
as
modulator
TMZ
in
GBM.
Validation
PANK4
across
various
TMZ‐resistant
GBM
cell
models,
patient‐derived
lines,
tissue
samples,
well
vivo
studies,
corroborates
potential
translational
significance
these
findings.
Moreover,
expression
induced
during
treatment,
and
associated
worse
clinical
outcome.
Furthermore,
Tandem
Mass
Tag
(TMT)‐based
quantitative
proteomic
approach,
reveals
that
abrogation
leads
significant
downregulation
host
central
roles
cellular
detoxification
response
oxidative
stress.
More
specifically,
cells
undergo
genotoxic
stress
exposure,
depletion
crucial
event
can
lead
accumulation
intracellular
reactive
oxygen
species
(ROS)
subsequent
death.
Collectively,
previously
unreported
role
mediating
unveiled.